Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT03382912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the efficacy of pegilodecakin in combination with nivolumab versus nivolumab alone in participants with metastatic non-small cell lung cancer as measured by objective response rate.
Study identification
- NCT ID
- NCT03382912
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 21, 2018
- Primary completion
- Aug 27, 2019
- Completion
- Mar 2, 2020
- Last update posted
- Sep 10, 2020
2018 – 2020
United States locations
- U.S. sites
- 35
- U.S. states
- 16
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates, P.C. | Tempe | Arizona | 85284 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| Glendale Adventist Medical Center | Los Angeles | California | 90017 | — |
| Redwood Regional Oncology Center | Santa Rosa | California | 95403 | — |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90602 | — |
| Rocky Mountain Cancer Center | Lone Tree | Colorado | 80124 | — |
| John B. Amos Cancer Center | Columbus | Georgia | 31904 | — |
| Covenant Clinic | Waterloo | Iowa | 50702 | — |
| Baptist Health Medical Group | Lexington | Kentucky | 40503 | — |
| MedStar Health Research Institute | Baltimore | Maryland | 21237 | — |
| Maryland Oncology Hematology, P.A. | Columbia | Maryland | 21044 | — |
| Frederick Memorial Hospital | Frederick | Maryland | 21701 | — |
| Sparrow Health System | Lansing | Michigan | 48912 | — |
| Hattiesburg Clinic | Hattiesburg | Mississippi | 39401 | — |
| The Valley Hospital - Luckow Pavilion | Westwood | New Jersey | 07675 | — |
| Broome Oncology LLC | Johnson City | New York | 13790 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Clinical Research Alliance, Inc. | New Hyde Park | New York | 11042 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Christ Hospital | Cincinnati | Ohio | 45219 | — |
| University of Toledo Medical Center | Toledo | Ohio | 43614-2598 | — |
| Charleston Hematology Oncology Associates | Charleston | South Carolina | 29414 | — |
| Mamie McFaddin Ward Cancer Center | Beaumont | Texas | 77702 | — |
| Texas Oncology - Dallas Presbyterian Hospital | Dallas | Texas | 75231 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology-Memorial City | Houston | Texas | 77024 | — |
| Millennium Oncology | Houston | Texas | 77090 | — |
| Joe Arrington Cancer Center | Lubbock | Texas | 79410 | — |
| Texas Oncology - Midland Allison Cancer Center | Midland | Texas | 79701 | — |
| US Oncology | The Woodlands | Texas | 77380 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Fairfax Northern Virginia Hematology Oncology, PC | Fairfax | Virginia | 22031 | — |
| Oncology and Hematology Associates of Southwest Virginia Inc | Roanoke | Virginia | 24014 | — |
| MultiCare Regional Cancer Center - Auburn | Tacoma | Washington | 98002 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03382912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2020 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03382912 live on ClinicalTrials.gov.